| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-90 |
Sentence |
denotes |
A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy. |
| TextSentencer_T2 |
91-262 |
Sentence |
denotes |
Systemic mastocytosis (SM) is a clonal hematologic disease showing abnormal growth and accumulation of mast cells (MC) in visceral organs with or without skin involvement. |
| TextSentencer_T3 |
263-301 |
Sentence |
denotes |
The clinical course in SM is variable. |
| TextSentencer_T4 |
302-364 |
Sentence |
denotes |
In fact, indolent and aggressive variants have been described. |
| TextSentencer_T5 |
365-466 |
Sentence |
denotes |
In addition, SM patients may acquire an associated hematologic clonal non-MC lineage disease (AHNMD). |
| TextSentencer_T6 |
467-602 |
Sentence |
denotes |
In some cases, hematologic parameters are indicative of slowly progressing SM although the clinical course remains indolent over years. |
| TextSentencer_T7 |
603-655 |
Sentence |
denotes |
These cases have been referred to as smouldering SM. |
| TextSentencer_T8 |
656-891 |
Sentence |
denotes |
We report on a smouldering patient presenting with typical skin lesions, hypercellular marrow with focal MC aggregates, persistent leukocytosis (20,000-30,000/microl) with eosinophilia (5-10%), marked lymphadenopathy, and splenomegaly. |
| TextSentencer_T9 |
892-953 |
Sentence |
denotes |
The C-KIT mutation Asp-816-Val confirmed the diagnosis of SM. |
| TextSentencer_T10 |
954-1100 |
Sentence |
denotes |
The clinical picture remained stable during an observation period of 10 years without signs of progression to an AHNMD or a high grade MC disease. |
| TextSentencer_T11 |
1101-1275 |
Sentence |
denotes |
These data show that some patients with SM can remain in a clinically indolent smouldering state over years even when presenting with marked eosinophilia and lymphadenopathy. |
| T1 |
0-90 |
Sentence |
denotes |
A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy. |
| T2 |
91-262 |
Sentence |
denotes |
Systemic mastocytosis (SM) is a clonal hematologic disease showing abnormal growth and accumulation of mast cells (MC) in visceral organs with or without skin involvement. |
| T3 |
263-301 |
Sentence |
denotes |
The clinical course in SM is variable. |
| T4 |
302-364 |
Sentence |
denotes |
In fact, indolent and aggressive variants have been described. |
| T5 |
365-466 |
Sentence |
denotes |
In addition, SM patients may acquire an associated hematologic clonal non-MC lineage disease (AHNMD). |
| T6 |
467-602 |
Sentence |
denotes |
In some cases, hematologic parameters are indicative of slowly progressing SM although the clinical course remains indolent over years. |
| T7 |
603-655 |
Sentence |
denotes |
These cases have been referred to as smouldering SM. |
| T8 |
656-891 |
Sentence |
denotes |
We report on a smouldering patient presenting with typical skin lesions, hypercellular marrow with focal MC aggregates, persistent leukocytosis (20,000-30,000/microl) with eosinophilia (5-10%), marked lymphadenopathy, and splenomegaly. |
| T9 |
892-953 |
Sentence |
denotes |
The C-KIT mutation Asp-816-Val confirmed the diagnosis of SM. |
| T10 |
954-1100 |
Sentence |
denotes |
The clinical picture remained stable during an observation period of 10 years without signs of progression to an AHNMD or a high grade MC disease. |
| T11 |
1101-1275 |
Sentence |
denotes |
These data show that some patients with SM can remain in a clinically indolent smouldering state over years even when presenting with marked eosinophilia and lymphadenopathy. |